Advertisement

Chromatographia

, Volume 81, Issue 4, pp 699–706 | Cite as

Development and Validation of an HPLC Method for the Simultaneous Determination of Flurbiprofen and Chlorhexidine Gluconate

  • Beril Deniz Işık
  • Ebru Türköz Acar
Short Communication
  • 177 Downloads

Abstract

Flurbiprofen (FBP) is a strong nonsteroidal anti-inflammatory drug which has analgesic, antipyretic and anti-inflammatory effects. Chlorhexidine gluconate (CHG) is a potent antibacterial agent. Nowadays, FBP and CHG as a combination are used in some pharmaceutical products. In this study, an analysis method was developed for the simultaneous determination of FBP and CHG using high performance liquid chromatography (HPLC) technique. During analysis, Agilent Poroshell 120 EC-C18 column was used as stationary phase with a guard column having the same properties. Sodium phosphate buffer solution (100 mM, pH 2.5) and acetonitrile were used as mobile phase. The chromatography was performed by gradient elution at a flow rate of 0.5 mL min−1. Analytes were detected at 248 nm using a diode array detector (DAD). The developed method was validated according to United States Pharmacopoeia. It was found to be linear in the concentration range between 1 and 25 ppm. Determination coefficient was 0.9999 for FBP and CHG. The developed method was applied successfully for HPLC analysis of commercial pharmaceutical products including FBP and CHG.

Graphical abstract

Keywords

HPLC Flurbiprofen Chlorhexidine gluconate Analysis Validation 

Notes

Acknowledgements

This work was financially supported by the Yeditepe University, İstanbul, Turkey.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

10337_2018_3485_MOESM1_ESM.docx (130 kb)
Supplementary material 1 (DOCX 130 kb)

References

  1. 1.
    Chao SH, Ho HT, Chen FA, Lin PY, Yu YC, Wu AB (2007) Identification of flurbiprofen and its photoproducts in methanol by gas chromatography–mass spectrometry. Biomed Chromatogr 21:527–533CrossRefGoogle Scholar
  2. 2.
    Russo M, Bloch M, Looze F, Morris C, Shephard A (2013) Flurbiprofen microgranules for relief of sore throat: a randomised, double-blind trial. Br J Gen Pract 63:149–155CrossRefGoogle Scholar
  3. 3.
    Másquio Fiorentino FA, Corrêa MA, Nunes Salgado HR (2013) Development and validation of a microbiological assay for determination of chlorhexidine digluconate in aqueous solution. Braz J Pharm Sci 49:351–358CrossRefGoogle Scholar
  4. 4.
    Másquio Fiorentino FA, Corrêa MA, Nunes Salgado HR (2010) Analytical methods for the determination of chlorhexidine: a review. Crit Rev Anal Chem 40:89–101CrossRefGoogle Scholar
  5. 5.
    Maha MY, Maan MN, Amer AT (2013) An in vitro evaluation of the antibacterial activity of experimental chlorhexidine gluconate solution using agar diffusion test. Tikrit J Dental Sci 1:94–100Google Scholar
  6. 6.
    Buchanan WW, Kassam YB (1986) European experience with flurbiprofen: a new analgesic/anti-inflammatory agent. Am J Med 80:145–152CrossRefGoogle Scholar
  7. 7.
    Sousa CP, Oliveira RC, Freirea TM et al (2017) Chlorhexidine digluconate on chitosan-magnetic iron oxide nanoparticles modified electrode: electroanalysis and mechanistic insights by computational simulations. Sensor Actuat B Chem 240:417–425CrossRefGoogle Scholar
  8. 8.
    Nikolin B, Imamović B, Medanhodžić-Vuk S, Šober M (2004) High performance liquid chromatography in pharmaceutical analyses. Bosn J Basic Med Sci 4:5–9Google Scholar
  9. 9.
    United States Pharmacopoeia (2000) United States Pharmacopoeial Convention, 24th edn. United States Pharmacopoeia, RockvilleGoogle Scholar
  10. 10.
    European Pharmacopeia (2005) Council of Europe, 5th edn. Strasbourg, FranceGoogle Scholar
  11. 11.
    Sajeev C, Jadhav PR, Ravishankar D, Saha RN (2002) Determination of flurbiprofen in pharmaceutical formulations by uv spectrophotometry and liquid chromatography. Anal Chim Acta 463:207–217CrossRefGoogle Scholar
  12. 12.
    Qayyum A, Najmi MH, Farooqi Z (2011) Determination of pharmacokinetics of flurbiprofen in Pakistani population using modified HPLC method. J Chromatogr Sci 49:108–113CrossRefGoogle Scholar
  13. 13.
    Hanif M, Nazer N, Chaurasiya V, Zia U (2016) Simultaneous determination of famotidine and flurbiprofen by high performance liquid chromatography. Trop J Pharm Res 15:605–611CrossRefGoogle Scholar
  14. 14.
    Hutzler JM, Fryeb RF, Tracya TS (2000) Sensitive and specific high-performance liquid chromatographic assay for 49-hydroxyflurbiprofen and flurbiprofen in human urine and plasma. J Chromatogr B 749:119–125CrossRefGoogle Scholar
  15. 15.
    Ünal DÖ, Güler S, Erol DD (2009) Development and validation of bioanalytical method for determination of flurbiprofen from human plasma by liquid chromatography. Hacet Univ J Fac Pharm 29:25–35Google Scholar
  16. 16.
    Mei C, Li B, Yin Q et al (2015) Liquid chromatography–tandem mass spectrometry for the quantification of flurbiprofen in human plasma and its application in a study of bioequivalence. J Chromatogr B 993–994:69–74CrossRefGoogle Scholar
  17. 17.
    Yılmaz B, Sahin H, Akba V, Erdem AF (2014) Determination of flurbiprofen in human plasma by gas chromatography with mass spectrometry and its pharmacokinetics. J AOAC Int 97:1061–1066CrossRefGoogle Scholar
  18. 18.
    Hamoudová R, Pospísilová M (2006) Determination of ibuprofen and flurbiprofen in pharmaceuticals by capillary zone electrophoresis. J Pharm Biomed Anal 41:1463–1467CrossRefGoogle Scholar
  19. 19.
    Yılmaz B, Alkan E (2015) Spectrofluorometric and uv spectrophotometric methods for the determination of flurbiprofen in pharmaceutical preparations. Res Rev Pharm Anal 4:1–8Google Scholar
  20. 20.
    Chandran S, Jadhav PR, Kharwade PB, Saha RN (2006) Rapid and sensitive spectrofluorimetric method for the estimation of selecoxib and flurbiprofen. Indian J Pharm Sci 68:20–25CrossRefGoogle Scholar
  21. 21.
    Xu Y, Wong GY (1999) Simultaneous determination of lignocaine hydrochloride, chlorhexidine gluconate, and triamcinolone acetonide in suspension by reversed-phase HPLC. J Liq Chromatogr Rel Technol 22:2071–2091CrossRefGoogle Scholar
  22. 22.
    Havlíková L, Matysová L, Nováková L, Hájková R, Solich P (2007) HPLC determination of chlorhexidine gluconate and p-chloroaniline in topical ointment. J Pharm Biomed Anal 43:1169–1173CrossRefGoogle Scholar
  23. 23.
    Dogan A, Bascı NE (2011) Development and validation of rp-hplc and ultraviolet spectrophotometric methods of analysis for the quantitative determination of chlorhexidine gluconate and benzydamine hydrochloride in pharmaceutical dosage forms. Curr Pharm Anal 7:167–175CrossRefGoogle Scholar
  24. 24.
    Abad-Villar EM, Etter SF, Thiel MA, Hauser PC (2006) Determination of chlorhexidine digluconate and polyhexamethylene biguanide in eye drops by capillary electrophoresis with contactless conductivity detection. Anal Chim Acta 561:133–137CrossRefGoogle Scholar
  25. 25.
    Borissova R, Mandjukova S (1997) Titrimetric and spectrophotometric determination of chlorhexidine digluconate in tooth pastes. Fresenius J Anal Chem 357:977–980CrossRefGoogle Scholar
  26. 26.
    United States Pharmacopeia (2014) United States Pharmacopeial Convention. United States Pharmacopeia, RockvilleGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Pharmaceutical Chemistry, Institute of Health SciencesYeditepe UniversityIstanbulTurkey
  2. 2.Analytical Chemistry, Faculty of PharmacyYeditepe UniversityIstanbulTurkey

Personalised recommendations